UBS O'Connor’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$181M Buy
+1,779,212
New +$143M 4.81% 9
2017
Q3
Sell
-59,671
Closed -$2.11M 372
2017
Q2
$2.11M Buy
+59,671
New +$1.84M 0.03% 253
2015
Q2
Sell
-40,000
Closed -$880K 835
2015
Q1
$880K Sell
40,000
-10,000
-20% -$254K 0.01% 548
2014
Q4
$1.37M Buy
+50,000
New +$1.22M 0.02% 322
2013
Q3
Sell
-330,000
Closed -$4.59M 472
2013
Q2
$4.59M Buy
+330,000
New +$3.58M 0.09% 250

Other funds holding EXAS

UBS O'Connor's EXAS Position: Q4 2025 in Review

UBS O'Connor opened a new position in Exact Sciences (EXAS) in Q4 2025: 1,779,212 shares worth $181M. The stake represents 4.81% of the portfolio and ranks #9 among its holdings. This is a return to the name: UBS O'Connor previously reported a position in EXAS as recently as Q2 2017.

UBS O'Connor first reported a position in EXAS in Q2 2013 and has held it in 5 quarters since. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • UBS O'Connor held 1,779,212 shares of Exact Sciences worth $181M as of Q4 2025.
  • Exact Sciences was a new UBS O'Connor position in Q4 2025.
  • Exact Sciences made up 4.81% of UBS O'Connor's portfolio in Q4 2025, its #9 holding.
  • UBS O'Connor first reported a position in Exact Sciences in Q2 2013 and has held it in 5 quarters since.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.